Kaplan-Meier analysis showed that overall survival was significantly shorter in pancreatic cancer patients with high NAMPT expression levels, whereas overall survival was not affected by NMNAT2 expression. The gene discussed is NMNAT2; the disease is pancreatic neoplasm.